Skip to main content

Table 1 Demographic and clinical characteristics of patients and HCs

From: Effects of electroconvulsive therapy on functional brain networks in patients with schizophrenia

Variables

Patients

 

HC

 

P

Pre-ECT

ECT1

ECT8

  

Gender(male/female)a

17/14

 

27/23

 

0.941

Age, yb

30.23±7.873

 

29.96±8.775

 

0.892

Education, yb

11.77±3.783

 

12.98±2.952

 

0.113

Illness duration, mo

10.94±8.96

 

-

 

-

PANSS

   

-

-

Positive

20.35±4.10

19.03±4.52

8.97±1.56

-

-

Negative

20.68±3.16

20.55±3.16

8.87±1.69

-

-

General

36.55±3.72

34.68±3.73

18.71±1.51

-

-

Total

78.48±6.01

75.10±5.76

36.94±3.28

-

-

Medication doses, mg/d

441.19 ±82.61.00

-

-

  1. aTwo-tailed χ2 test
  2. bTwo-tailed t tests; Medication doses: doses calculated from power transformation for chlorpromazine equivalent